INDIANAPOLIS — Regenstrief Institute investigator and Indiana University Center for Aging Research scientist Noll Campbell, Pharm.D., is one of only 15 early career investigators nationwide selected to participate in the annual Charleston Conference on Alzheimer’s Disease in Charleston, S.C. He is the first doctor of pharmacy to be selected for this honor.
Each year, the honored early career investigators are invited to submit proposals for a one-year project to be conducted with researchers at their own institution, with outside colleagues or in collaboration with as many as two of the other honorees. Leading Alzheimer’s disease researchers attending the Charleston Conference evaluate the proposals on the basis of innovation, significance and feasibility. The 2015 award winners will present their research at the 2017 Charleston Conference.
Dr. Campbell is an aging brain pharmacoepidemiologist. His research focuses on identifying adverse cognitive effects of medications and medication adherence in older adults with cognitive impairment. He received the Tony and Mary Hulman Health Achievement Award in the field of geriatrics and gerontology from the Indiana Public Health Foundation in 2014.
“Dr. Campbell brings a unique perspective on research to improve the care of older adults with Alzheimer’s disease,” said Regenstrief Institute investigator and IU Center for Aging Research founding director Christopher Callahan, M.D., who is also the Cornelius and Yvonne Pettinga Professor in Aging Research at the IU School of Medicine. “He understands that medications are both part of the problem and part of the solution for persons with cognitive impairment.”
In addition to his Regenstrief Institute and IU Center for Aging Research appointments, Dr. Campbell is an adjunct assistant professor of medicine at the IU School of Medicine, a research assistant professor in the Department of Pharmacy Practice at the Purdue University College of Pharmacy and a clinical pharmacy specialist with Eskenazi Health.